← The SEC Ephemeris: the whole map
Lykos Therapeutics this action
In the graph: all 1 documents (7 pages).
- Application
- NDA 215455
- Ticker
- Lykos Therapeutics
- Product
- this action
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- August 8, 2024
From FDA letters and SEC filings. Not investment or medical advice.